1. Home
  2. MYGN vs CBAN Comparison

MYGN vs CBAN Comparison

Compare MYGN & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.89

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Logo Colony Bankcorp Inc.

CBAN

Colony Bankcorp Inc.

HOLD

Current Price

$20.97

Market Cap

436.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
CBAN
Founded
1991
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
436.3M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
MYGN
CBAN
Price
$4.89
$20.97
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.64
N/A
AVG Volume (30 Days)
1.3M
232.3K
Earning Date
05-05-2026
04-22-2026
Dividend Yield
N/A
2.29%
EPS Growth
N/A
16.91
EPS
N/A
1.59
Revenue
$771,400,000.00
N/A
Revenue This Year
$6.89
$35.41
Revenue Next Year
$5.35
$4.84
P/E Ratio
N/A
$13.17
Revenue Growth
2.33
N/A
52 Week Low
$3.76
$14.54
52 Week High
$8.59
$21.46

Technical Indicators

Market Signals
Indicator
MYGN
CBAN
Relative Strength Index (RSI) 54.92 68.22
Support Level $4.23 $15.96
Resistance Level $5.67 $21.04
Average True Range (ATR) 0.27 0.38
MACD 0.03 0.14
Stochastic Oscillator 87.97 82.41

Price Performance

Historical Comparison
MYGN
CBAN

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

Share on Social Networks: